Company Announcement Oncology Venture publishes Interim Report for the period January – September 2019

NEXT STORY
Stemline Therapeutics to Present at Piper Jaffray’s 31st Annual Healthcare Conference
PREV STORY
New Micro-Simulation Study in Cancer Medicine Finds Epi proColon® Provides Clinically Meaningful Reductions in Incidence and Mortality of Colorectal Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Yiviva Announces Dosing of First Patient in Phase 2b Study of First-Line YIV-906 Plus Sorafenib Combination Therapy in the Treatment of Hepatocellular Carcinoma

author_avatar
NASDAQ Market News

Arcturus Reports Positive Preclinical Data for its COVID-19 Vaccine Candidate

author_avatar
NASDAQ Market News

iBio Announces Financial Results for Fiscal Year Ended June 30, 2020

author_avatar
NASDAQ Market News